Expression and function of toll-like receptor 4 and inflammasomes in cardiac fibroblasts and myofibroblasts: IL-1β synthesis, secretion, and degradation-Reference-Cited by-同舟云学术

Expression and function of toll-like receptor 4 and inflammasomes in cardiac fibroblasts and myofibroblasts: IL-1β synthesis, secretion, and degradation

Published:2016-06 Issue: Volume:74 Page:96-105
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Boza Pia,Ayala Pedro,Vivar Raúl,Humeres Claudio,Cáceres Felipe Tapia,Muñoz Claudia,García Lorena,Hermoso Marcela A.,Díaz-Araya Guillermo

Funder

FONDECYT

CONICYT

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference59 articles.

1. Toll-like receptor 2 signalling;Akira;Nat. Rev. Immunol.,2004

2. Beta(2)-adrenergic receptor regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by cardiac fibroblast autophagy and collagen degradation;Aránguiz-Urroz;Biochim. Biophys. Acta,2011

3. Innate immune signaling in cardiac ischemia;Arslan;Nat. Rev. Cardiol.,2011

4. Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility;Avlas;Antioxid. Redox Signal.,2011

5. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases;Caforio;Eur. Heart J.,2013

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NLRP3 inflammasome and pyroptosis in cardiovascular diseases and exercise intervention;Frontiers in Pharmacology;2024-04-12

2. Deciphering the Role of Pyroptosis Impact on Cardiovascular Diseases;Current Drug Targets;2023-11

3. Perindopril improves cardiac fibrosis through targeting the AngII/AT1R pathway;Cellular and Molecular Biology;2023-09-30

4. Interferon-β decreases LPS-induced neutrophil recruitment to cardiac fibroblasts;Frontiers in Cell and Developmental Biology;2023-09-20

5. Cisplatin cycles treatment sustains cardiovascular and renal damage involving TLR4 and NLRP3 pathways;Pharmacology Research & Perspectives;2023-07-09